Literature DB >> 16376279

Focal glucose hypermetabolism in interictal state of West syndrome.

Tomohiro Kumada1, Hidehiko Okazawa, Hiroshi Yamauchi, Toshiyuki Kitoh, Masatoshi Ito.   

Abstract

This report concerns two siblings from a tetrad, both of whom had West syndrome with atypical findings on positron emission tomography using [(18)F] fluorodeoxyglucose. One manifested periventricular leukoencephalopathy, and the other had periventricular leukoencephalopathy as well as porencephaly because of fetal distress and brain parenchymal hemorrhage in the neonatal period. They developed West syndrome at the age of 9 months. Fluorodeoxyglucose-positron emission tomography study performed after cessation of their seizures revealed an increase in glucose metabolism. The corresponding region presented low-level accumulation in [(11)C]flumazenil positron emission tomography. The patients remained seizure-free for more than 1 month, and their electroencephalograms only occasionally disclosed sporadic paroxysmal discharges. Because of the decreased density of benzodiazepine receptor in these lesions, the activity of the excitatory neuron system may overexpress that of the inhibitory neuron system, thus resulting in epileptogenesis of the lesions. It is suggested that fluorodeoxyglucose and flumazenil-positron emission tomography revealed functional abnormalities and that epileptogenesis of these patients is still active even when the patient is seizure-free and there are mild epileptogenic discharges on electroencephalogram.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16376279     DOI: 10.1016/j.pediatrneurol.2005.05.019

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  1 in total

1.  Transient focal cortical increase of interictal glucose metabolism in Sturge-Weber syndrome: implications for epileptogenesis.

Authors:  Bálint Alkonyi; Harry T Chugani; Csaba Juhász
Journal:  Epilepsia       Date:  2011-04-11       Impact factor: 5.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.